NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Carboplatin
Radiation: 3D-RT or IMRT

First Posted Date: 2011-02-03

Last Posted Date: 2021-01-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 92

Registration Number: NCT01289353

Locations: 🇺🇸
NYU Cancer Center, New York, New York, United States

Image Guided Therapy in the Treatment of Gliomas

Not Applicable

Terminated

Conditions: Glioma

Interventions: Procedure: Diffusion-weighted magnetic resonance imaging
Procedure: Perfusion-weighted magnetic resonance imaging
Procedure: Functional magnetic resonance imaging
Procedure: Magnetic resonance spectroscopic imaging
Procedure: Therapeutic conventional surgery
Procedure: Quality-of-life assessment
Procedure: Radiation therapy treatment planning/simulation
Procedure: Intensity-modulated radiation therapy
Other: Questionnaire administration

First Posted Date: 2010-12-21

Last Posted Date: 2017-08-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT01263821

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

Women With Epilepsy: Pregnancy Outcomes and Deliveries

Completed

Conditions: Epilepsy

First Posted Date: 2010-12-14

Last Posted Date: 2016-03-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 199

Registration Number: NCT01259310

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
North Shore Long Island Jewish Health System, Great Neck, New York, United States
🇺🇸
NYU Langone Medical Center, New York, New York, United States

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

Not Applicable

Withdrawn

Conditions: Parkinsons Disease
Lewy Bodies Disease

Interventions: Drug: Armodafinil

First Posted Date: 2010-12-09

Last Posted Date: 2021-08-23

Lead Sponsor: NYU Langone Health

Registration Number: NCT01256905

Locations: 🇺🇸
NYU Parkinsons and Movement Disorders Center, New York, New York, United States

Living With Aphasia: An International Study

Terminated

Conditions: Aphasia

First Posted Date: 2010-11-04

Last Posted Date: 2016-06-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT01234090

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis

Not Applicable

Terminated

Conditions: Multiple Sclerosis

Interventions: Device: Magnetic Resonance Imaging

First Posted Date: 2010-10-22

Last Posted Date: 2017-08-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 69

Registration Number: NCT01226654

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function

Completed

Conditions: Cardiac Electrical Function

Interventions: Device: 12 Lead Glove

First Posted Date: 2010-10-11

Last Posted Date: 2017-11-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 300

Registration Number: NCT01218334

Locations: 🇺🇸
New York University Medical Center, New York, New York, United States

Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia

Phase 3

Completed

Conditions: Familial Dysautonomia

Interventions: Drug: Carbidopa
Drug: Placebo

First Posted Date: 2010-09-30

Last Posted Date: 2016-03-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 12

Registration Number: NCT01212484

Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)

Not Applicable

Completed

Conditions: Rheumatoid Arthritis
Periodontal Disease
Psoriatic Arthritis

Interventions: Drug: doxycycline
Drug: vancomycin

First Posted Date: 2010-09-10

Last Posted Date: 2015-01-13

Lead Sponsor: NYU Langone Health

Target Recruit Count: 178

Registration Number: NCT01198509

Locations: 🇺🇸
NYU Hospital for Joint Diseases, New York, New York, United States
🇺🇸
Bellevue Hospital, New York, New York, United States

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Phase 3

Completed

Conditions: Opiate Dependence

Interventions: Drug: Extended-Release Naltrexone
Behavioral: Motivational Enhancement Counseling

First Posted Date: 2010-08-12

Last Posted Date: 2016-04-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 48

Registration Number: NCT01180647

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States
🇺🇸
New York City Department of Correction, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy